Trial Profile
VaxOnco-sponsored phase I trial of a folate receptor alpha-targeted breast/ovarian cancer therapeutic vaccine.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Mar 2014
Price :
$35
*
At a glance
- Drugs Cancer vaccine (Primary) ; Denileukin diftitox; Granulocyte macrophage colony stimulating factor
- Indications Breast cancer; Ovarian cancer
- Focus Adverse reactions
- Sponsors VaxOnco
- 27 Jul 2011 New trial record